Quest Diagnostics Incorporated
DGX
Rangering i aksjer
#931
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus,... Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
Aksjekurs
$236.69
Sist synkronisert: 2026-10-20
Markedsverdi
$26.12B
Endring (1 dag)
0.80%
Endring (1 år)
28.19%
Land
US
Handel Quest Diagnostics Incorporated (DGX)
Kategori
Healthcare
Antall utestående aksjer for Quest Diagnostics Incorporated (DGX)
Antall utestående aksjer per June 2026: 110.00M
Ifølge Quest Diagnostics Incorporated sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 110.00M. Ved slutten av December 2024 hadde selskapet 111.00M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Quest Diagnostics Incorporated (DGX) fra 2000 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| 2026 (TTM) | 110.00M | -0.90% |
| 2025 | 111.00M | 0.00% |
| 2024 | 111.00M | -0.89% |
| 2023 | 112.00M | -3.45% |
| 2022 | 116.00M | -7.20% |
| 2021 | 125.00M | -6.72% |
| 2020 | 134.00M | 0.00% |
| 2019 | 134.00M | -1.47% |
| 2018 | 136.00M | -0.73% |
| 2017 | 137.00M | -2.14% |
| 2016 | 140.00M | -2.78% |
| 2015 | 144.00M | -0.69% |
| 2014 | 145.00M | -4.61% |
| 2013 | 152.00M | -4.16% |
| 2012 | 158.60M | -0.06% |
| 2011 | 158.70M | -9.68% |
| 2010 | 175.70M | -5.49% |
| 2009 | 185.90M | -4.32% |
| 2008 | 194.30M | 0.55% |
| 2007 | 193.24M | -1.90% |
| 2006 | 196.99M | -2.40% |
| 2005 | 201.83M | -0.94% |
| 2004 | 203.75M | -1.56% |
| 2003 | 206.97M | 7.29% |
| 2002 | 192.91M | 3.40% |
| 2001 | 186.56M | 4.20% |
| 2000 | 179.04M | 0.00% |
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| 371.00M | 237.27% |
US
|
|
| 705.30M | 541.18% |
US
|
|
| 143.28M | 30.25% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 156.36% |
US
|
